# Long-term Evaluation on Height and Weight in Patients With MPS II Who Started Treatment at < 6 Years of Age

> **NCT02455622** · PHASE4 · COMPLETED · sponsor: **Shire** · enrollment: 21 (actual)

## Conditions studied

- Hunter Syndrome

## Interventions

- **DRUG:** Elaprase for intravenous (IV) infusion

## Key facts

- **NCT ID:** NCT02455622
- **Lead sponsor:** Shire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10-28
- **Primary completion:** 2025-07-29
- **Final completion:** 2025-07-29
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2026-04-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02455622

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02455622, "Long-term Evaluation on Height and Weight in Patients With MPS II Who Started Treatment at < 6 Years of Age". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02455622. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*